Recent Posts
- 1st CAR T-Cell Therapy in China for Myeloma Now Under Review
- Novel Immunotherapy QXL138AM Wins Orphan Drug Status in US
- CYT-338 Shows Anticancer Activity in Preclinical Tests
- CAR T-cell Therapy Safe, Effective in Treatment-resistant Myeloma: Study
- Ninlaro as Oral Combo Therapy Fails at Trial in Heavily Treated Patients